• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SK&F 97426 - A:一种新型胆汁酸螯合剂,在体外对胆汁酸的亲和力高于消胆胺,且解离速率比消胆胺慢。

SK&F 97426-A: a novel bile acid sequestrant with higher affinities and slower dissociation rates for bile acids in vitro than cholestyramine.

作者信息

Benson G M, Alston D R, Hickey D M, Jaxa-Chamiec A A, Whittaker C M, Haynes C, Glen A, Blanchard S, Cresswell S R, Suckling K E

机构信息

SmithKline Beecham Pharmaceuticals, The Frythe, Welwyn, Herts, U.K.

出版信息

J Pharm Sci. 1997 Jan;86(1):76-81. doi: 10.1021/js960207j.

DOI:10.1021/js960207j
PMID:9002463
Abstract

SK&F 97426-A is a novel bile acid sequestrant that is threefold more potent than cholestyramine at increasing bile acid excretion in the hamster. SK&F 97426-A is a quaternary alkylammonium polymethacrylate that was selected for comparison with cholestyramine in vivo because of its superior in vitro bile acid binding properties. Association, dissociation, affinity, and capacity experiments were performed under physiologically relevant conditions with the most abundant bile acids found in human bile. The bile acids came to equilibrium with SK&F 97426-A and cholestyramine within approximately 30 min and 6 min, respectively. SK&F 97426-A and cholestyramine had similar capacities for all the bile acids (between 2.5 and 4 mmol/g) and both had similar, very high affinities and slow dissociation rates for the dihydroxy bile acids. However, SK&F 97426-A had much higher affinities for the trihydroxy bile acids glycocholic acid and taurocholic acid than did cholestyramine. Dissociation of glycocholic acid and taurocholic acid from SK&F 97426-A was also much slower (27 and 25%, respectively, dissociated after 60 min) than from cholestyramine (89 and 84%, respectively, dissociated after 60 min). The higher affinities and slower dissociation rates of the trihydroxy bile acids for and from SK&F 97426-A probably account for the increased potency of SK&F 97426-A over cholestyramine in vivo.

摘要

SK&F 97426 - A是一种新型胆汁酸螯合剂,在增加仓鼠胆汁酸排泄方面的效力是消胆胺的三倍。SK&F 97426 - A是一种季铵化聚甲基丙烯酸酯,因其在体外具有优异的胆汁酸结合特性而被选用于体内与消胆胺进行比较。在生理相关条件下,使用人胆汁中含量最丰富的胆汁酸进行了结合、解离、亲和力和容量实验。胆汁酸分别在约30分钟和6分钟内与SK&F 97426 - A和消胆胺达到平衡。SK&F 97426 - A和消胆胺对所有胆汁酸的容量相似(在2.5至4 mmol/g之间),并且对二羟基胆汁酸都具有相似的、非常高的亲和力和缓慢的解离速率。然而,SK&F 97426 - A对三羟基胆汁酸甘氨胆酸和牛磺胆酸的亲和力比消胆胺高得多。甘氨胆酸和牛磺胆酸从SK&F 97426 - A的解离也比从消胆胺慢得多(60分钟后分别解离27%和25%)(消胆胺在60分钟后分别解离89%和84%)。三羟基胆汁酸对SK&F 97426 - A的较高亲和力和较慢解离速率可能解释了SK&F 97426 - A在体内比消胆胺效力更高的原因。

相似文献

1
SK&F 97426-A: a novel bile acid sequestrant with higher affinities and slower dissociation rates for bile acids in vitro than cholestyramine.SK&F 97426 - A:一种新型胆汁酸螯合剂,在体外对胆汁酸的亲和力高于消胆胺,且解离速率比消胆胺慢。
J Pharm Sci. 1997 Jan;86(1):76-81. doi: 10.1021/js960207j.
2
SK&F 97426-A a more potent bile acid sequestrant and hypocholesterolaemic agent than cholestyramine in the hamster.在仓鼠体内,SK&F 97426 - A是一种比消胆胺更有效的胆汁酸螯合剂和降胆固醇药。
Atherosclerosis. 1993 Jun;101(1):51-60. doi: 10.1016/0021-9150(93)90101-y.
3
In vitro studies to investigate the reasons for the low potency of cholestyramine and colestipol.
J Pharm Sci. 1993 Jan;82(1):80-6. doi: 10.1002/jps.2600820118.
4
Binding of bile acids to cholestyramine at gastric pH conditions.在胃pH条件下胆汁酸与考来烯胺的结合。
J Pharm Sci. 1975 Nov;64(11):1887-9. doi: 10.1002/jps.2600641133.
5
Comparison of the effects of cholestyramine and aluminium hydroxide on the biliary bile acid excretion in rats. An experimental model for the depletion of bile acids in bile.
Acta Biol Med Ger. 1980;39(6):705-9.
6
Binding properties in vitro of antacids for conjugated bile acids.抗酸剂对结合胆汁酸的体外结合特性
Gastroenterology. 1977 Sep;73(3):556-9.
7
Equilibrium and kinetic factors influencing bile sequestrant efficacy.影响胆汁螯合剂疗效的平衡和动力学因素。
Pharm Res. 1992 May;9(5):670-6. doi: 10.1023/a:1015862329303.
8
[Binding of bile acids to antacids].[胆汁酸与抗酸剂的结合]
Verh Dtsch Ges Inn Med. 1977;83:1714-7.
9
The ability of antacids and cholestyramine to bind bile acids: effect of pH.抗酸剂和消胆胺结合胆汁酸的能力:pH值的影响
Scand J Gastroenterol. 1986 Sep;21(7):789-94. doi: 10.3109/00365528609011118.
10
In vitro binding of mixed micellar solutions of fatty acids and bile salts by cholestyramine.考来烯胺对脂肪酸和胆盐混合胶束溶液的体外结合作用。
Proc Soc Exp Biol Med. 1973 May;143(1):89-92. doi: 10.3181/00379727-143-37259.

引用本文的文献

1
Liraglutide and Colesevelam Change Serum and Fecal Bile Acid Levels in a Randomized Trial With Patients With Bile Acid Diarrhea.利拉鲁肽和考来维仑在伴有胆酸腹泻患者的随机试验中改变血清和粪便胆汁酸水平。
Clin Transl Gastroenterol. 2024 Nov 1;15(11):e00772. doi: 10.14309/ctg.0000000000000772.
2
Bile Acid Sequestrants Based on Natural and Synthetic Gels.基于天然和合成凝胶的胆汁酸螯合剂
Gels. 2023 Jun 19;9(6):500. doi: 10.3390/gels9060500.